Skip to main content
Fig. 3 | Lipids in Health and Disease

Fig. 3

From: In vitro assessment of nutraceutical compounds and novel nutraceutical formulations in a liver-steatosis-based model

Fig. 3

MTT assay for single nutraceutical compounds (a) and formulations (b). The figure shows the cell viability percentage of HepG2 cells after 30 min of H2O2 (50 μM) treatment and after nutraceutical compounds incubation. b and c are relative to two groups of different experiments in wich intracellular fat difference in the averaged data proved not to be significant using t-student test p > 0.05

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X